Generalised myasthenia gravis - bridging therapy authority application form (PB395)

Use this form to apply for PBS-subsidised bridging therapy with ravulizumab, rozanolixizumab or zilucoplan for generalised myasthenia gravis.

Page last updated: 1 July 2026.
QC 83704